Jane Street’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,077
Closed -$65.6K 12045
2025
Q3
$65.6K Buy
5,077
+3,321
+189% +$49.4K ﹤0.01% 10273
2025
Q2
$31.6K Buy
1,756
+1,400
+393% +$28K ﹤0.01% 9279
2025
Q1
$7.71K Buy
+356
New +$7.38K ﹤0.01% 9219
2023
Q4
Sell
-86
Closed -$11.4K 9644
2023
Q3
$11.4K Buy
+86
New +$13.3K ﹤0.01% 8374
2023
Q2
Sell
-125
Closed -$21K 9330
2023
Q1
$21K Buy
125
+36
+40% +$7.58K ﹤0.01% 8635
2022
Q4
$19.1K Buy
89
+37
+71% +$14K ﹤0.01% 8621
2022
Q3
$20K Buy
52
+5
+11% +$2.83K ﹤0.01% 9200
2022
Q2
$20K Buy
+47
New +$22.7K ﹤0.01% 9161
2022
Q1
Sell
-226
Closed -$250K 10846
2021
Q4
$250K Sell
226
-403
-64% -$876K ﹤0.01% 8477
2021
Q3
$2.42M Buy
+629
New +$1.98M ﹤0.01% 4083
2021
Q2
Sell
-52
Closed -$123K 10230
2021
Q1
$104K Buy
+52
New +$78.2K ﹤0.01% 8625
2020
Q4
Sell
-36
Closed -$30K 7944
2020
Q3
$30K Sell
36
-124
-78% -$110K ﹤0.01% 6992
2020
Q2
$152K Buy
+160
New +$160K ﹤0.01% 6544
2018
Q3
Sell
-39
Closed -$17K 5546
2018
Q2
$17K Buy
+39
New +$23.8K ﹤0.01% 4871

Other funds holding PAVM

Jane Street's PAVM Position: Q4 2025 in Review

Jane Street sold out of PAVmed (PAVM) in Q4 2025, closing a stake of 5,077 shares — an estimated $65.6K sold.

Jane Street first reported a position in PAVM in Q2 2018 and held it in 14 quarters. The position peaked at $2.42M in Q3 2021. 28 funds tracked by Wall St. Rank hold PAVM as of Q4 2025.

  • Jane Street reported no remaining PAVmed position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 5,077 PAVmed shares in Q4 2025, an estimated $65.6K.
  • Jane Street first reported a position in PAVmed in Q2 2018 and held it in 14 quarters.
  • Jane Street's PAVmed position peaked at $2.42M in Q3 2021.
  • 28 funds tracked by Wall St. Rank held PAVmed as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.